NDC 49502-251

SEMGLEE

Insulin Glargine-yfgn

SEMGLEE is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Mylan Specialty L.p.. The primary component is Insulin Glargine.

• Product ID: 49502-251_07c27823-59b9-4d2a-978f-eb95220fbbd9
• NDC: 49502-251
• Product Type: Human Prescription Drug
• Proprietary Name: SEMGLEE
• Generic Name: Insulin Glargine-yfgn
• Dosage Form: Injection, Solution
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2021-11-15
• Marketing Category: BLA /
• Application Number: BLA761201
• Labeler Name: Mylan Specialty L.P.
• Substance Name: INSULIN GLARGINE
• Active Ingredient Strength: 100 [iU]/mL
• Pharm Classes: Insulin [CS],Insulin Analog [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 49502-251-35

1 SYRINGE in 1 CARTON (49502-251-35) > 3 mL in 1 SYRINGE

• Marketing Start Date: 2022-10-01
• NDC Exclude Flag: N
• Sample Package?: Y

Drug Details

NDC Crossover Matching brand name "SEMGLEE" or generic name "Insulin Glargine-yfgn"

NDC	Brand Name	Generic Name
49502-195	SEMGLEE	insulin glargine
49502-196	SEMGLEE	insulin glargine
49502-250	SEMGLEE	insulin glargine-yfgn
49502-251	SEMGLEE	insulin glargine-yfgn
50090-5835	SEMGLEE	insulin glargine
49502-393	Insulin Glargine	insulin glargine-yfgn
49502-394	Insulin Glargine	insulin glargine-yfgn